Hereditary transthyretin amyloidosis polyneuropathy in patients with carpal tunnel syndrome in Russia

Trial Identifier:	D8451R00001
Sponsor:	AstraZeneca
Start Date:	December 2023
Primary Completion Date:	December 2024
Study Completion Date:	December 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia, Russia	Moscow, Russia, Russia
Russia, Russia	Saint-Petersburg, Russia, Russia, 194354

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.